Olivero, Chiara
Carbone, Federico
Liberale, Luca https://orcid.org/0000-0003-1472-7975
Montecucco, Fabrizio
Article History
Received: 19 August 2024
Accepted: 23 October 2024
First Online: 8 November 2024
Declarations
:
: LL is coinventor on the International Patent WO/2020/226993 filed in April 2020; the patent relates to the use of antibodies which specifically bind interleukin-1a to reduce various sequelae of ischemia–reperfusion injury to the central nervous system. LL has received financial support from the Swiss Heart Foundation and the Novartis Foundation for Medical-Biological Research outside of this work. The other authors report no conflict of interests.